Filing Flows › DarioHealth (DRIO) › Q2 2026
DarioHealth (DRIO) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 11, 2026
DarioHealth (DRIO) reported revenue of $5.2M for the second quarter 2026 (Q2 2026), -4% from a year earlier and -7% from the quarter before. Operating margin was -125.1%, net loss $7.9M (153.1% of revenue).
DarioHealth, Q2 2026: revenue $5.2M (-4% year over year), operating margin -125.1%, net loss $7.9M, operating cash flow −$6.1M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.2M | -7% | -4% |
| Operating profit | −$6.5M | — | — |
| Net earnings | −$7.9M | — | — |
| Operating cash flow | −$6.1M | — | — |
What changed
Revenue was $5.2M in Q2 2026, down 4% year over year and down 7% from the previous quarter. Hardware and Consumable Products was the largest line at 50% of revenue. Services lost $1.1M year over year (down 29%), 560% of the total change.
Gross margin was 61.7%, up 6.5 points from Q2 2025. Operating costs exceeded revenue by $6.5M, an operating margin of -125.1%. Operating expenses fell 20% while revenue fell 4%. The quarter ended with a net loss of $7.9M, narrower than the previous quarter's $8.2M loss.
Operating cash flow was −$6.1M. Non-cash charges added back $515K of depreciation and amortization and $632K of share-based compensation. Working capital and other items added $694K. Capital expenditures of $38K exceeded it, leaving free cash flow of −$6.1M.
Questions
What was DarioHealth's revenue in the second quarter 2026?
DarioHealth (DRIO) reported revenue of $5.2M for the second quarter 2026 (Q2 2026), -4% from a year earlier and -7% from the quarter before.
Was DarioHealth profitable in the second quarter 2026?
Operating loss was $6.5M (-125.1% of revenue) and net loss $7.9M.
Source: DarioHealth 10-Q on SEC EDGAR.